Nearly two-thirds of Medicare claims for 26 outpatient drugs analyzed by ICER were rejected within 30 days of initial submission due to coverage restrictions or pretreatment reviews.

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

Drug pricing policy, insurance prior authorization, and essential drug shortages affecting medication affordability and access.